Discontinued — last reported Q4 '22

Business Segments · Restructuring Reserve

IngenioRx Segment — Restructuring Reserve

Elevance Health IngenioRx Segment — Restructuring Reserve remained flat by 0.0% to $1.00M in Q4 2022 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $1.00M to $1.00M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ4 2020
Last reportedQ4 2022

How to read this metric

An increase suggests management is planning significant operational changes or downsizing, while a decrease indicates the completion of restructuring activities or a reduction in planned reorganization scope.

Detailed definition

This represents the accrued liability set aside to cover costs associated with reorganizing or streamlining the operatio...

Peer comparison

Similar to restructuring accruals found in other healthcare services or PBM segments, often compared against total segment operating expenses to gauge the scale of transformation.

Metric ID: elv_segment_ingeniorx_segment_restructuring_reserve

Historical Data

7 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22
Value$1.00M$1.00M$1.00M$1.00M$1.00M$1.00M$1.00M
QoQ Change+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%
YoY Change+0.0%+0.0%+0.0%
Range$1.00M$1.00M
CAGR+0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak6+ quarters growth

Frequently Asked Questions

What is Elevance Health's ingeniorx segment — restructuring reserve?
Elevance Health (ELV) reported ingeniorx segment — restructuring reserve of $1.00M in Q4 2022.
How has Elevance Health's ingeniorx segment — restructuring reserve changed year-over-year?
Elevance Health's ingeniorx segment — restructuring reserve decreased by 0.0% year-over-year, from $1.00M to $1.00M.
What does ingeniorx segment — restructuring reserve mean?
The estimated future costs set aside for reorganizing the pharmacy benefit management business.